Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mucositis × Lidocaine × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Colonic Neoplasms 3 Breast Neoplasms 3 Pain 2 Wounds and Injuries 1 Stomatitis 1 Postoperative Hemorrhage 1 Mucositis 1 Malignant Pleural Neoplasm 1 Leiomyoma 1 Inflammatory Bowel Diseases 1 Ileus 1 Head and Neck Neoplasms 1 Feeding and Eating Disorders 1 Diverticulitis 1 Colorectal Neoplasms 1 Cancer Pain 1

Interventions

Cisplatin 4 angiotensin I (1-7) 3 Radiotherapy 3 Radiation 3 Injections 3 Water 2 RRx-001 2 Interleukin 1 Receptor Antagonist Protein 2 Drug Therapy 2 Amifostine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 kang-lai-te 1 hydrated silica gel-based toothpaste 1 fish oil triglycerides 1 calcium phosphate 1 brilacidin 1 anise oil 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Vaccinium myrtillus extract 1 Tramadol 1 Therapeutics 1 Surgical Procedures, Operative 1 Sorbic Acid 1 Sodium Bicarbonate 1 Selenomethionine 1 Radiotherapy, Intensity-Modulated 1 Propolis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡